1. INFORMATION ON TENDERING  1.1 Participation  The European Centre for Disease prevention and Control (ECDC) is an agency of the European Union,  established by the European Parliament and Council Regulation 851/2004 of 21 April 2004. Further  information about ECDC can be found on the ECDC website www.ecdc.europa.eu.  This tender process is governed by Directive 2014/24/EU and Regulation 2018/1046.  Participation in this procurement procedure is open on equal terms to all natural and legal persons coming  within the scope of the Treaties, as well as to international organisations, established in the European  Union, European Economic Area and Stabilisation and Association Agreements countries.  For tenderers established in the United Kingdom (UK): please be aware that after the UK's withdrawal from  the EU, the rules of access to EU procurement procedures of economic operators established in third  countries will apply to tenderers from the UK depending on the outcome of the negotiations. In case such  3  3.3 Timely delivery of contributions to editing and writing of meeting documents and  minutes. ......................................................................................................................11  3.1  Preparing the report ...................................................................................................11  3.2  Participation of the contractor(s) in: ..........................................................................11  -  ESAC-Net-related preparatory meetings; ...................................................................11  -  ESAC-Net Disease Network Coordination Committee meetings (including jointly with  other related Disease Network Coordination Committees);......................................11  -  ESAC-Net network meetings (including jointly with other related networks); and ...11  -  on request in selected expert meetings. ....................................................................11  2.4  Place of performance and number of meetings.........................................................13  2.5  Intellectual property rights .........................................................................................14  2.6  Moral rights of the authors.........................................................................................14  3.  EVALUATION AND AWARD ....................................................................................................14  3.1  Verification of non-exclusion ......................................................................................14  3.2  Selection criteria .........................................................................................................15  3.3  Award..........................................................................................................................18  4.  ANNEXES................................................................................................................................20 